CJC-1295 ( no DAC) + IPAMORELIN
Price range: $ 85.00 through $ 115.00 - or subscribe
The CJC-1295 No DAC + Ipamorelin blend pairs a modified 30-amino-acid GHRH analog (CJC-1295 without DAC) with the selective pentapeptide GHRP Ipamorelin — the most-cited GHRH+GHRP combination in research literature.
Research-grade specs
- Components: CJC-1295 No DAC (GHRH) + Ipamorelin (GHRP)
- CJC-1295 length: 30 amino acids
- Half-life: ~30 minutes (No DAC variant)
Studied applications
- GHRH + GHRP synergy research (most-studied combination)
- Pulsatile GH-release studies
- Stacking comparison vs CJC-1295 With DAC + Ipamorelin
- Body-composition research
Quality & trust
- ≥99% HPLC purity, third-party tested
- Mass spectrometry identity confirmation
- LAL endotoxin testing on every batch
- Batch-specific Certificate of Analysis included
- USA same-day shipping (orders before 2pm CT M-F)
Related research: Sermorelin · Ipamorelin alone · Tesamorelin + Ipamorelin blend
Research literature
CJC-1295 has been the subject of 28 peer-reviewed publications indexed in PubMed. Selected recent literature for research reference:
- Mendias CL et al. (2026). Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. PMID: 41966639
- Coutinho LFD et al. (2026). A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review. J Sports Med Phys Fitness. PMID: 41880199
- Uçaktürk E et al. (2026). Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry. J Pharm Biomed Anal. PMID: 41138283
- Rahman OF et al. (2026). Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. J Am Acad Orthop Surg Glob Res Rev. PMID: 41490200
- Mayfield CK et al. (2026). Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. Am J Sports Med. PMID: 41476424
References are provided for research reference only. Inclusion of literature does not constitute a recommendation, endorsement, or claim for any specific use of LiveWell Peptides products. Products are sold for laboratory and research use only and are not intended for human consumption, injection, topical application, or any other administration to the human body.
| Quantity | Price | Discount |
|---|---|---|
| 3-5 | $ 81.60 | 4% |
| 6-8 | $ 78.20 | 8% |
| 10-15 | $ 75.65 | 11% |
| 16+ | $ 85.00 | $ 0.00 |
Description
CJC-1295 (no DAC) combined with Ipamorelin is a lab-grade GHRH/GHS peptide blend supplied for laboratory research and in-vitro studies. Available in 5 mg and 10 mg vial options, this blend is intended for researchers studying pulsatile GH release and related cellular mechanisms. Product content and references are provided for educational and experimental research purposes only. This product is not a pharmaceutical and must not be used in humans or animals. Purchasers are responsible for compliance with all applicable local, state, and federal regulations. Reference links and supporting literature are linked from the product page for researcher review.
Reference Link CJC: Click Here
Reference Link IPAMORELIN: Click Here
You may also like
5-Amino-1MQ — NNMT Inhibitor | Research Grade
$ 45.99 - or subscribe and save up to 10%
BPC-157 Peptide — Body Protection Compound | Research Grade
$ 85.99 - or subscribe
CJC-1295 ( no DAC) + IPAMORELIN
Price range: $ 85.00 through $ 115.00 - or subscribe
